CIDRAP newsletters options
By the end of today 2.6 million young American children will have gotten their first shot.
Data show that people taking immunosuppressive drugs, including cancer patients, are not at higher risk.
For the 4th week in a row, the rate of new global COVID-19 cases rose, led by surges in Europe.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
A coalition of organizations from academia, healthcare, and the pharmaceutical industry sent a letter today to G7 governments calling for greater engagement in tackling antimicrobial resistance (AMR) and boosting the pipeline for new antibiotics.
Pfizer has applied for emergency use authorization from the FDA for Paxlovid, its COVID-19 drug.
More than 95% of the state's available inpatient hospital beds are filled with patients.
Of the patients taking fluoxetine (Prozac), 9.8% died, versus 13.3% of control patients, a 28% reduction.
An automated text messaging system for adult COVID-19 outpatients developed at Penn Medicine saved two lives a week during the first US pandemic surge, and users were 68% less likely than controls to die, finds a study today in the Annals of Internal Medicine.
A report today from Scotland highlights reduced antibiotic use in the country since it adopted a One Health approach to combatting antimicrobial resistance (AMR).
About 65% of Austrians are vaccinated, a low level for Western Europe.
COVID-19, however, has slowed progress and much work remains, a global survey reveals.
Women need resources to navigate this uncertain time, the authors say.
Most Americans will take precautions for Thanksgiving, a new poll shows, as a hold on a federal vaccine mandate is upheld.
Antibiotic prescribing in general practice in England fell significantly during the first 12 months of the COVID-19 pandemic compared with the previous year, according to data released last week by Antibiotic Research UK (ANTRUK).
Most respiratory protective equipment (RPE) used in healthcare is not designed for women or racial minorities amid a dearth of research into how facial dimensions across sex and race affect respirator performance, according to a systematic review and meta-analysis published late last week in BMJ Global Health.
Black, Hispanic, and Asian people are at higher risk for infection and an ICU stay, a large study finds.
In US developments, Colorado—in the grips of a COVID-19 surge—opened up vaccine boosters to all adults.
Though the nation's flu activity is still at low levels, the number of detections has increased in recent weeks, mostly due to the H3N2 strain and with 90% of cases in people ages 5 to 24, the US Centers for Disease Control and Prevention (CDC) said today in an update that covers last week.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Nov 11
